B cell depletion therapy in autoimmune diseases

Frontiers in Bioscience

Volumn 12, Issue 7, 2007, Pages 2546-2567

  Sanz, Iñaki ^a   Anolik, Jennifer H ^a   Looney, R John ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Autoimmunity; B cells; Immune system; Immunity; Review; Tolerance

Indexed keywords

AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE DEPLETION; REVIEW;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; B-LYMPHOCYTES; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTE DEPLETION;

EID: 34247638346     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2254     Document Type: Review

References (219)

1. Martin, F. & A. C. Chan: B Cell Immunobiology in Disease: Evolving Concepts from the Clinic. Annu. Rev. Immunol. 24, (2006)
2. Tanja Lövgren, M.-L. E. U. B. G. V. A. L. R.: Induction of interferon-a production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum 50, 1861-1872 (2004) (Pubitemid 38725099)
3. Lee, D. M., D. S. Friend, M. F. Gurish, C. Benoist, D. Mathis & M. B. Brenner: Mast Cells: A Cellular Link Between Autoantibodies and Inflammatory Arthritis. Science, 297, 1689-1692 (2002) (Pubitemid 35000781)
4. Eisenberg, R. & R. J. Looney: The therapeutic potential of anti-CD20: "What do B-cells do?" Clin. Immunol, 117, 207-213 (2005) (Pubitemid 43005207)
5. Chan, O. T. & M. J. Shlomchik: Cutting edge: B cells promote CD8+ T cell activation in MRL-Fas (lpr) mice independently of MHC class I antigen presentation. J. Immunol 164, 1658-62 (2000) (Pubitemid 30108712)
6. Chan, O. T., L. G. Hannum, A. M. Haberman, M. P. Madaio & M. J. Shlomchik: A novel mouse with B cells but lacking serum antibody reveals an antibodyindependent role for B cells in murine lupus. J. Exp. Med 189, 1639-48 (1999)
7. Chan, O. T., M. P. Madaio & M. J. Shlomchik: The central and multiple roles of B cells in lupus pathogenesis. Immunol. Rev. 169, 107-21 (1999) (Pubitemid 29338727)
8. Wong, F. S., L. Wen, M. Tang, M. Ramanathan, I. Visintin, J. Daugherty, L. G. Hannum, C. A. Janeway, Jr. & M. J. Shlomchik: Investigation of the Role of B-Cells in Type 1 Diabetes in the NOD Mouse. Diabetes, 53, 2581-2587 (2004) (Pubitemid 39299265)
9. O'Neill, S. K., M. J. Shlomchik, T. T. Glant, Y. Cao, P. D. Doodes & A. Finnegan: Antigen-Specific B Cells Are Required as APCs and Autoantibody-Producing Cells for Induction of Severe Autoimmune Arthritis. J Immunol, 174, 3781-3788 (2005) (Pubitemid 40354091)
10. Looney, R. J., A. J., D. Campbell, R. E. Felgar, F. Young, L. J. Arend, J. A. Sloand, J. Rosenblatt & I. Sanz: B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose-escalation trial of rituximab. Arthritis Rheum, 50, 2580-2589 (2004) (Pubitemid 39062719)
11. Ansel, K. M., V. N. Ngo, P. L. Hyman, S. A. Luther, R. Forster, J. D. Sedgwick, J. L. Browning, M. Lipp & J. G. Cyster: A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature, 406, 309-314 (2000) (Pubitemid 30604409)
12. Fu, Y.-X. & D. D. Chaplin: Development and maturation of secondary lymphoid tissues Ann. Rev. Immunol, 17, 399-433 (1999) (Pubitemid 29241130)
13. Mariathasan, S., M. Matsumoto, F. Baranyay, M. H. Nahm, O. Kanagawa & D. D. Chaplin: Absence of lymph nodes in lymphotoxin-alpha (LT alpha)-deficient mice is due to abnormal organ development, not defective lymphocyte migration. J. Inflamm, 45, 72-8 (1995)
14. Matsumoto, M., S. F. Lo, C. J. Carruthers, J. Min, S. Mariathasan, G. Huang, D. R. Plas, S. M. Martin, R. S. Geha, M. H. Nahm & D. D. Chaplin: Affinity maturation without germinal centres in lymphotoxin-alpha-deficient mice. Nature, 382, 462-6 (1996) (Pubitemid 26264864)
15. Matsumoto, M., S. Mariathasan, M. H. Nahm, F. Baranyay, J. J. Peschon & D. D. Chaplin: Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers. Science, 271, 1289-91 (1996) (Pubitemid 26082651)
16. Fu, Y.-X., H. Molina, M. Matsumoto, G. Huang, J. Min & D. D. Chaplin: Lymphotoxin-alpha (LTalpha) Supports Development of Splenic Follicular Structure That Is Required for IgG Responses. J. Exp. Med., 185, 2111-2120 (1997) (Pubitemid 27265995)
17. Luther, S. A., T. Lopez, W. Bai, D. Hanahan & J. G. Cyster: BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity, 12, 471-81 (2000)
18. Yu, P., Y. Wang, R. K. Chin, L. Martinez-Pomares, S. Gordon, M. H. Kosco-Vibois, J. Cyster & Y. X. Fu: B cells control the migration of a subset of dendritic cells into B cell follicles via CXC chemokine ligand 13 in a lymphotoxin-dependent fashion. J Immunol, 168, 5117-23. (2002) (Pubitemid 34495976)
19. Crowley, M. T., C. R. Reilly & D. Lo: Influence of lymphocytes on the presence and organization of dendritic cell subsets in the spleen. J. Immunol 163, 4894-4900 (1999) (Pubitemid 29501254)
20. Lorenz, R. G., D. D. Chaplin, K. G. McDonald, J. S. McDonough & R. D. Newberry: Isolated Lymphoid Follicle Formation Is Inducible and Dependent Upon Lymphotoxin-Sufficient B Lymphocytes, Lymphotoxin {beta} Receptor, and TNF Receptor I Function. J Immunol, 170, 5475-5482 (2003) (Pubitemid 36617835)
21. Kabashima, K., T. A. Banks, K. M. Ansel, T. T. Lu, C. F. Ware & J. G. Cyster: Intrinsic Lymphotoxin-[beta] Receptor Requirement for Homeostasis of Lymphoid Tissue Dendritic Cells. Immunity, 22, 439-450 (2005) (Pubitemid 40545110)
22. Ware, C. F.: Network communications: lymphotoxins, LIGHT, and TNF. Annu Rev Immunol, 23, 787-819 (2005) (Pubitemid 40563185)
23. MacLennan, I. C., A. Gulbranson-Judge, K. M. Toellner, M. Casamayor-Palleja, E. Chan, D. M. Sze, S. A. Luther & H. A. Orbea: The changing preference of T and B cells for partners as T-dependent antibody responses develop. Immunol. Rev, 156, 53-66 (1997) (Pubitemid 27197192)
24. Berney, C., S. Herren, C. A. Power, S. Gordon, L. Martinez-Pomares & M. H. Kosco-Vilbois: A member of the dendritic cell family that enters B cell follicles and stimulates primary antibody responses identified by a mannose receptor fusion protein. Journal of Experimental Medicine, 190, 851-60 (1999) (Pubitemid 29451630)
25. Ngo, V. N., R. J. Cornall & J. G. Cyster: Splenic T zone development is B cell dependent. J. Exp. Med., 194, 1649-1660 (2001) (Pubitemid 33126815)
26. Hjelmstrom, P.: Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J Leukoc Biol, 69, 331-339 (2001) (Pubitemid 32221435)
27. McDonald, K. G., J. S. McDonough & R. D. Newberry: Adaptive Immune Responses Are Dispensable for Isolated Lymphoid Follicle Formation: Antigen-Naive, Lymphotoxin-Sufficient B Lymphocytes Drive the Formation of Mature Isolated Lymphoid Follicles. J Immunol, 174, 5720-5728 (2005) (Pubitemid 40593215)
28. Armengol, M.-P., C. B. Cardoso-Schmidt, M. Fernandez, X. Ferrer, R. Pujol-Borrell & M. Juan: Chemokines Determine Local Lymphoneogenesis and a Reduction of Circulating CXCR4+ T and CCR7 B and T Lymphocytes in Thyroid Autoimmune Diseases. J Immunol, 170, 6320-6328 (2003) (Pubitemid 36682618)
29. Söderström, N. & A. Biörklund: Organization of the invading lymphoid tissue in human lymphoid thyroiditis. Scand J Immunol, 3, 295-301 (1974)
30. Meijer, C. J., L. B. van de Putte, F. Eulderink, R. Kleinjan, G. Lafeber & G. T. Bots: Characteristics of mononuclear cell populations in chronically inflamed synovial membranes. J Pathol, 121, 1-8 (1977) (Pubitemid 8012239)
31. Young, C. L., T. C. Adamson, 3rd, J. H. Vaughan & R. I. Fox: Immunohistologic characterization of synovial membrane lymphocytes in rheumatoid arthritis. Arthritis Rheum, 27, 32-9 (1984) (Pubitemid 14176534)
32. Randen, I., O. J. Mellbye, O. Forre & J. B. Natvig: The identification of germinal centres and follicular dendritic cell networks in rheumatoid synovial tissue. Scand J Immunol, 41, 481-6 (1995)
33. Schroder, A. E., A. Greiner, C. Seyfert & C. Berek: Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. PNAS, 93, 221-225 (1996) (Pubitemid 26038131)
34. Stott, D. I., F. Hiepe, M. Hummel, G. Steinhauser & C. Berek: Antigen-driven Clonal Proliferation of B Cells within the Target Tissue of an Autoimmune Disease. The Salivary Glands of Patients with Sjogren's Syndrome. J. Clin. Invest., 102, 938-946 (1998) (Pubitemid 28419239)
35. Prineas, J. W.: Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord. Science, 203, 1123-5 (1979) (Pubitemid 9148091)
36. Corcione, A., S. Casazza, E. Ferretti, D. Giunti, E. Zappia, A. Pistorio, C. Gambini, G. L. Mancardi, A. Uccelli & V. Pistoia: Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. PNAS, 101, 11064-11069 (2004) (Pubitemid 38989584)
37. Leprince, C., S. Cohen-Kaminsky, S. Berrih-Aknin, B. Vernet-Der Garabedian, D. Treton, P. Galanaud & Y. Richard: Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis. J Immunol, 145, 2115-2122 (1990) (Pubitemid 20343374)
38. Peterson, K. S., J.-F. Huang, J. Zhu, V. D'Agati, X. Liu, N. Miller, M. G. Erlander, M. R. Jackson & R. J. Winchester: Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J. Clin. Invest., 113, 1722-1733 (2004) (Pubitemid 39071664)
39. Mosnier, J. F., C. Degott, P. Marcellin, D. Henin, S. Erlinger & J. P. Benhamou: The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study. Hepatology, 17, 366-71 (1993) (Pubitemid 23072809)
40. Fujimura, Y., R. Kamoi & M. Iida: Pathogenesis of aphthoid ulcers in Crohn's disease: correlative findings by magnifying colonoscopy, electron microscopy, and immunohistochemistry. Gut, 38, 724-732 (1996) (Pubitemid 26167481)
41. Yeung, M. M. W., S. Melgar, V. Baranov, A. Oberg, A. Danielsson, S. Hammarstrom & M. L. Hammarstrom: Characterisation of mucosal lymphoid aggregates in ulcerative colitis: immune cell phenotype and TcR-gamma delta expression. Gut, 47, 215-227 (2000) (Pubitemid 30489765)
42. Katakai, T., T. Hara, M. Sugai, H. Gonda & A. Shimizu: Th1-Biased Tertiary Lymphoid Tissue Supported by CXC Chemokine Ligand 13-Producing Stromal Network in Chronic Lesions of Autoimmune Gastritis. J Immunol, 171, 4359-4368 (2003) (Pubitemid 37238714)
43. Takemura, S., P. A. Klimiuk, A. Braun, J. J. Goronzy & C. M. Weyand: T Cell Activation in Rheumatoid Synovium Is B Cell Dependent. J Immunol, 167, 4710-4718 (2001) (Pubitemid 32954353)
44. Roosnek, E. & A. Lanzavecchia: Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells. J. Exp. Med., 173, 487-489 (1991)
45. Epstein, M. M., F. Di Rosa, D. Jankovic, A. Sher & P. Matzinger: Successful T cell priming in B cell-deficient mice. J. Exp. Med., 182, 915-922 (1995)
46. Banchereau, J. & R. M. Steinman: Dendritic cells and the control of immunity. Nature, 392, 245-252 (1998) (Pubitemid 28155090)
47. Kurt-Jones, E. A., D. Liano, K. A. HayGlass, B. Benacerraf, M. S. Sy & A. K. Abbas: The role of antigenpresenting B cells in T cell priming in vivo. Studies of B cell-deficient mice. J Immunol, 140, 3773-3778 (1988)
48. Ron, Y. & J. Sprent: T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes. J Immunol, 138, 2848-2856 (1987) (Pubitemid 17072758)
49. Janeway, C., Jr, J. Ron & M. Katz: The B cell is the initiating antigen-presenting cell in peripheral lymph nodes. J Immunol, 138, 1051-1055 (1987) (Pubitemid 17017883)
50. Macaulay, A. E., R. H. DeKruyff & D. T. Umetsu: Antigen-Primed T Cells from B Cell-Deficient JHD Mice Fail to Provide B Cell Help. J Immunol, 160, 1694-1700 (1998) (Pubitemid 28106454)
51. Ronchese, F. & B. Hausmann: B lymphocytes in vivo fail to prime naive T cells but can stimulate antigenexperienced T lymphocytes. J. Exp. Med., 177, 679-690 (1993) (Pubitemid 23104279)
52. Stockinger, B., T. Zal, A. Zal & D. Gray: B cells solicit their own help from T cells. J. Exp. Med., 183, 891-899 (1996) (Pubitemid 26113961)
53. van Essen, D., P. Dullforce & D. Gray: Role of B cells in maintaining helper T-cell memory. Philosophical Transactions of the Royal Society of London - Series B: Biological Sciences, 355, 351-5 (2000) (Pubitemid 30199477)
54. Schultze, J. L., S. Michalak, J. Lowne, A. Wong, M. H. Gilleece, J. G. Gribben & L. M. Nadler: Human Non-Germinal Center B Cell Interleukin (IL)-12 Production Is Primarily Regulated by T Cell Signals CD40 Ligand, Interferon gamma, and IL-10: Role of B Cells in the Maintenance of T Cell Responses. J. Exp. Med., 189, 1-12 (1999)
55. Diaz-de-Durana, Y., G. T. Mantchev, R. J. Bram & A. Franco: TACI-BLyS signaling via B-cell-dendritic cell cooperation is required for naive CD8+ T-cell priming in vivo. Blood, 107, 594-601 (2006) (Pubitemid 43076383)
56. Mamula, M. J., R. H. Lin, C. A. Janeway, Jr. & J. A. Hardin: Breaking T cell tolerance with foreign and self coimmunogens. A study of autoimmune B and T cell epitopes of cytochrome c. J. Immunol., 49, 789-95 (1992)
57. Chan, O. & M. J. Shlomchik: A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice. J. Immunol., 160, 51-9 (1998) (Pubitemid 28116714)
58. Wellmann, U., M. Letz, A. Schneider, K. Amann & T. H. Winkler: An Ig {micro}-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW) F1 mice. Int. Immunol., 13, 1461-1469 (2001) (Pubitemid 33133875)
59. Moulin, V., F. Andris, K. Thielemans, C. Maliszewski, J. Urbain & M. Moser: B Lymphocytes Regulate Dendritic Cell (DC) Function In Vivo: Increased Interleukin 12 Production by DCs from B Cell-deficient Mice Results in T Helper Cell Type 1 Deviation. J. Exp. Med., 192, 475-482 (2000) (Pubitemid 30666248)
60. Skok, J., J. Poudrier & D. Gray: Dendritic Cell-Derived IL-12 Promotes B Cell Induction of Th2 Differentiation: A Feedback Regulation of Th1 Development. J Immunol, 163, 4284-4291 (1999) (Pubitemid 29474494)
61. Denis, O., D. Latinne, F. Nisol & H. Bazin: Resting B cells can act as antigen presenting cells in vivo and induce antibody responses. Int Immunol, 5, 71-8 (1993) (Pubitemid 23038690)
62. Gajewski, T. F., M. Pinnas, T. Wong & F. W. Fitch: Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. J Immunol, 146, 1750-1758 (1991)
63. Sun, C.-M., E. Deriaud, C. Leclerc & R. Lo-Man: Upon TLR9 Signaling, CD5+ B Cells Control the IL-12-Dependent Th1-Priming Capacity of Neonatal DCs. Immunity, 22, 467-477 (2005) (Pubitemid 40545112)
64. Amedei, A., C. Romagnani, M. Benagiano, A. Azzurri, F. Fomia, F. Torrente, A. Plebani, M. M. D'Elios & G. Del Prete: Preferential Th1 profile of T helper cell responses in X-linked (Bruton's) agammaglobulinemia. Eur J Immunol, 31, 1927-34 (2001) (Pubitemid 32547354)
65. Johansson-Lindbom, B., S. Ingvarsson & C. A. K. Borrebaeck: Germinal Centers Regulate Human Th2 Development. J Immunol, 171, 1657-1666 (2003) (Pubitemid 36969794)
66. Linton, P.-J., B. Bautista, E. Biederman, E. S. Bradley, J. Harbertson, R. M. Kondrack, R. C. Padrick & L. M. Bradley: Costimulation via OX40L Expressed by B Cells Is Sufficient to Determine the Extent of Primary CD4 Cell Expansion and Th2 Cytokine Secretion In Vivo. J. Exp. Med., 197, 875-883 (2003) (Pubitemid 36437864)
67. Okamoto, H.: Effect of rituximab in refractory SLE: inhibition of Th1? Rheumatology, 45, 121-a-122 (2006)
68. Wagner, M., H. Poeck, B. Jahrsdoerfer, S. Rothenfusser, D. Prell, B. Bohle, E. Tuma, T. Giese, J. W. Ellwart, S. Endres & G. Hartmann: IL-12p70-Dependent Th1 Induction by Human B Cells Requires Combined Activation with CD40 Ligand and CpG DNA. J Immunol, 172, 954-963 (2004) (Pubitemid 38113754)
69. Lisa M. Ebert, Michael P. H. Alois B. L. B. M.: B cells alter the phenotype and function of follicular-homing CXCR5 T cells. Eur. J. Immunol., 34, 3562-3571 (2004) (Pubitemid 40012174)
70. Breitfeld, D., L. Ohl, E. Kremmer, J. Ellwart, F. Sallusto, M. Lipp & R. Forster: Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J. Exp. Med., 192, 1545-52 (2000)
71. Kim, C. H., L. S. Rott, I. Clark-Lewis, D. J. Campbell, L. Wu & E. C. Butcher: Subspecialization of CXCR5 (+) T Cells. B helper activity is focused in a germinal centerlocalized subset of cxcr5 (+) t cells. J Exp Med, 193, 1373-82. (2001)
72. Akiba, H., K. Takeda, Y. Kojima, Y. Usui, N. Harada, T. Yamazaki, J. Ma, K. Tezuka, H. Yagita & K. Okumura: The Role of ICOS in the CXCR5+ Follicular B Helper T Cell Maintenance In Vivo. J Immunol, 175, 2340-2348 (2005) (Pubitemid 41113843)
73. Ozaki, K.: A critical role for IL-21 in regulating immunoglobulin production. Science, 298, 1630-1634 (2002) (Pubitemid 35387203)
74. Vinuesa, C. G., S. G. Tangye, B. Moser & C. R. Mackay: Follicular B helper T cells in antibody responses and autoimmunity Nature Reviews Immunology, 5, 853-865 (2005) (Pubitemid 41581667)
75. Vinuesa, C. G.: A novel RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature, 435, 452-458 (2005) (Pubitemid 40734237)
76. Olson, T. S., G. Bamias, M. Naganuma, J. Rivera-Nieves, T. L. Burcin, W. Ross, M. A. Morris, T. T. Pizarro, P. B. Ernst, F. Cominelli & K. Ley: Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease. J. Clin. Invest., 114, 389-398 (2004) (Pubitemid 39071611)
77. Yu, S., P. K. Maiti, M. Dyson, R. Jain & H. Braley-Mullen: B cell-deficient NOD. H-2h4 mice have CD4+CD25+ T regulatory cells that inhibit the development of spontaneous autoimmune thyroiditis. J. Exp. Med., 203, 349-358 (2006) (Pubitemid 43290844)
78. Bayry, J., S. Lacroix-Desmazes, M. D. Kazatchkine, O. Hermine, D. F. Tough & S. V. Kaveri: Modulation of Dendritic Cell Maturation and Function by B Lymphocytes. J Immunol, 175, 15-20 (2005) (Pubitemid 40884295)
79. Kaser, A., S. Dunzendorfer, F. A. Offner, O. Ludwiczek, B. Enrich, R. O. Koch, W. W. Cruikshank, C. J. Wiedermann & H. Tilg: B Lymphocyte-Derived IL-16 Attracts Dendritic Cells and Th Cells. J Immunol, 165, 2474-2480 (2000) (Pubitemid 30660692)
80. Krzysiek, R., E. A. Lefevre, W. Zou, A. Foussat, J. Bernard, A. Portier, P. Galanaud & Y. Richard: Antigen Receptor Engagement Selectively Induces Macrophage Inflammatory Protein-1{alpha} (MIP-1{alpha}) and MIP-1{beta} Chemokine Production in Human B Cells. J Immunol, 162, 4455-4463 (1999) (Pubitemid 29314842)
81. Lazdina, U., M. Alheim, J. Nystrom, C. Hultgren, G. Borisova, I. Sominskaya, P. Pumpens, D. L. Peterson, D. R. Milich & M. Sallberg: Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent. J Gen Virol, 84, 139-146 (2003) (Pubitemid 36113559)
82. Bergmann, C. C., C. Ramakrishna, M. Kornacki & S. A. Stohlman: Impaired T Cell Immunity in B Cell-Deficient Mice Following Viral Central Nervous System Infection. J Immunol, 167, 1575-1583 (2001) (Pubitemid 32703158)
83. Thomsen, A. R., J. Johansen, O. Marker & J. P. Christensen: Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B celldeficient mice. J Immunol, 157, 3074-3080 (1996) (Pubitemid 126450067)
84. Franco, M. A. & H. B. Greenberg: Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J. Virol., 69, 7800-7806 (1995)
85. Liu, Y. & A. Mullbacher: Activated B Cells Can Deliver Help for the in vitro Generation of Antiviral Cytotoxic T Cells. PNAS, 86, 4629-4633 (1989) (Pubitemid 19164603)
86. Angeli, V., F. Ginhoux, J. Llodra, L. Quemeneur, P. S. Frenette, M. Skobe, R. Jessberger, M. Merad & G. J. Randolph: B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity, 24, 203-15 (2006) (Pubitemid 43214589)
87. Byrne, S. N. & G. M. Halliday: B Cells Activated in Lymph Nodes in Response to Ultraviolet Irradiation or by Interleukin-10 Inhibit Dendritic Cell Induction of Immunity. J. Invest. Derm, 124, 570-578 (2005) (Pubitemid 40381580)
88. Pistoia, V.: Production of cytokines by human B cells in health and disease. Immunol. Today, 18, 343-350 (1997) (Pubitemid 27314471)
89. Johansson-Lindbom, B. & C. A. K. Borrebaeck: Germinal Center B Cells Constitute a Predominant Physiological Source of IL-4: Implication for Th2 Development In Vivo. J Immunol, 168, 3165-3172 (2002) (Pubitemid 34250375)
90. Harris, D. P., L. Haynes, P. C. Sayles, D. K. Duso, S. M. Eaton, N. M. Lepak, L. L. Johnson, S. L. Swain & F. E. Lund: Reciprocal regulation of polarized cytokine production by effector B and T cells. Nature Immunol, 1, 475-482 (2000)
91. Lund, F. E., B. A. Garvy, T. D. Randall & D. P. Harris: Regulatory roles for cytokine-producing B cells in infection and autoimmune disease. Curr Dir Autoimmun, 8, 25-54 (2005)
92. Taylor-Robinson, A. W. & R. S. Phillips: Reconstitution of B-cell-depleted mice with B cells restores Th2-type immune responses during Plasmodium chabaudi chabaudi infection. Infect. Immun., 64, 366-370 (1996) (Pubitemid 26009379)
93. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray & S. M. Anderton: B cells regulate autoimmunity by provision of IL-10. Nat Immunol, 3, 944-50. (2002) (Pubitemid 35154008)
94. Mauri, C., D. Gray, N. Mushtaq & M. Londei: Prevention of Arthritis by Interleukin 10-producing B Cells. J. Exp. Med., 197, 489-501 (2003) (Pubitemid 36278604)
95. Tian, J., D. Zekzer, L. Hanssen, Y. Lu, A. Olcott & D. L. Kaufman: Lipopolysaccharide-activated b cells downregulate th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol, 167, 1081-9. (2001) (Pubitemid 32660868)
96. Wei, B., P. Velazquez, O. Turovskaya, K. Spricher, R. Aranda, M. Kronenberg, L. Birnbaumer & J. Braun: Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets. PNAS, 102, 2010-2015 (2005) (Pubitemid 40262003)
97. Mizoguchi, A., E. Mizoguchi, H. Takedatsu, R. S. Blumberg & A. K. Bhan: Chronic Intestinal Inflammatory Condition Generates IL-10-Producing Regulatory B Cell Subset Characterized by CD1d Upregulation. Immunity, 16, 219-230 (2002) (Pubitemid 34211962)
98. Tsitoura, D. C., V. P. Yeung, R. H. DeKruyff & D. T. Umetsu: Critical role of B cells in the development of T cell tolerance to aeroallergens. Int. Immunol., 14, 659-667 (2002) (Pubitemid 34649721)
99. Mizoguchi, A. & A. K. Bhan: A Case for Regulatory B Cells. J Immunol, 176, 705-710 (2006) (Pubitemid 43099663)
100. Llorente, L., W. Zou, Y. Levy, Y. Richaud-Patin, J. Wijdenes, J. Alcocer-Varela, B. Morel-Fourrier, J. C. Brouet, D. Alarcon-Segovia & P. Galanaud: Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med., 181, 839-44 (1995)
101. Llorente, L., Y. Richaud-Patin, C. Garcia-Padilla, E. Claret, J. Jakez-Ocampo, M. H. Cardiel, J. Alcocer-Varela, L. Grangeot-Keros, D. Alarcon-Segovia, J. Wijdenes, P. Galanaud & D. Emilie: Clinical and biologic effects of antiinterleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum, 43, 1790-800 (2000)
102. Gortz, B., S. Hayer, K. Redlich, J. Zwerina, M. Tohidast-Akrad, B. Tuerk, C. Hartmann, G. Kollias, G. Steiner, J. S. Smolen & G. Schett: Arthritis induces lymphocytic bone marrow inflammation and endosteal bone formation. J Bone Miner Res, 19, 990-8 (2004) (Pubitemid 41103456)
103. Novobrantseva, T. I., G. R. Majeau, A. Amatucci, S. Kogan, I. Brenner, S. Casola, M. J. Shlomchik, V. Koteliansky, P. S. Hochman & A. Ibraghimov: Attenuated liver fibrosis in the absence of B cells. J. Clin. Invest., 115, 3072-3082 (2005) (Pubitemid 41567572)
104. Bhogal, R. K. & C. A. Bona: B cells: no longer bystanders in liver fibrosis. J. Clin. Invest., 115, 2962-2965 (2005) (Pubitemid 41567558)
105. St. Clair, E. W, Tedder, F. T.: New prospects for autoimmune disease therapy: B cells on deathwatch. Arthritis Rheum, 54, 1-9 (2006) (Pubitemid 43122179)
106. Vallin, H., A. Perers, G. V. Alm & L. Ronnblom: Anti-Double-Stranded DNA Antibodies and Immunostimulatory Plasmid DNA in Combination Mimic the Endogenous IFN-{alpha} Inducer in Systemic Lupus Erythematosus. J Immunol, 163, 6306-6313 (1999)
107. Korganow, A. S., H. Ji, S. Mangialaio, V. Duchatelle, R. Pelanda, T. Martin, C. Degott, H. Kikutani, K. Rajewsky, J. L. Pasquali, C. Benoist & D. Mathis: From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity, 10, 451-61 (1999) (Pubitemid 29205481)
108. Anolik, J. H. & M. Aringer: New treatments for SLE: cell-depleting and anti-cytokine therapies. Best Practice & Research Clinical Rheumatology, 19, 859-878 (2005) (Pubitemid 41258587)
109. Anolik, J., T. Owen, J. Barnard & I. Sanz: Anti-Tumor Necrosis Factor Therapy in Rheumatoid Arthritis Alters B Lymphocyte Dynamics. Arthritis Rheum, 52, S677 (2005)
110. Looney, Anolik & Sanz: New Therapies for Systemic Lupus Erythematosus: Cellular Targets. Rheum. Dis. Clin. North. Amer., 32, 201-215 (2006) (Pubitemid 43290600)
111. Neelapu, S. S., L. W. Kwak, C. B. Kobrin, C. W. Reynolds, J. E. Janik, K. Dunleavy, T. White, L. Harvey, R. Pennington, M. Stetler-Stevenson, E. S. Jaffe, S. M. Steinberg, R. Gress, F. Hakim & W. H. Wilson: Vaccineinduced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma. Nat Med, 11, 986-991 (2005) (Pubitemid 41294445)
112. Eisenberg, R.: Update on rituximab. Ann Rheum Dis, 64, iv55-57 (2005) (Pubitemid 41532020)
113. McLaughlin, P., C. A. White, A. J. Grillo-Lopez & D. G. Maloney: Clinical status and optimal use of rituximab for B-cell lymphomas. Oncology (Huntington), 12, 1763-9; discussion 1769-70, 1775-7, (1998)
114. Looney, R. J.: B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis. Rheumatology, 44, ii13-17 (2005)
115. Pestronk, A., J. Florence, T. Miller, R. Choksi, M. T. Al-Lozi & T. D. Levine: Treatment of IgM antibody associated polyneuropathies using rituximab. J Neurol Neurosurg Psychiatry, 74, 485-489 (2003) (Pubitemid 36379372)
116. Levine, T. D. & A. Pestronk: IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab. Neurology, 52, 1701-(1999)
117. Todd, D. L.: Rituximab in the treatment of dermatomyositis: An open-label pilot study. Arthritis Rheum, 52, 601-607 (2005)
118. Peter Brœndstrup, O. W. B. O. J. N. B. A. J. N. T. C. P. B. H. I. A. K. S. T. M. A. N. A. P. H.: Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura. Amer. J. Hematol, 78, 275-280 (2005) (Pubitemid 40471119)
119. Zecca, M., B. Nobili, U. Ramenghi, S. Perrotta, G. Amendola, P. Rosito, M. Jankovic, P. Pierani, P. De Stefano, M. R. Bonora & F. Locatelli: Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. Blood, 101, 3857-3861 (2003) (Pubitemid 36857857)
120. Cooper, N., R. Stasi, S. Cunningham-Rundles, M. A. Feuerstein, J. P. Leonard, S. Amadori & J. B. Bussel: The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. British Journal of Haematology, 125, 232-239 (2004) (Pubitemid 38534976)
121. Kim, H.-J., V. Krenn, G. Steinhauser & C. Berek: Plasma Cell Development in Synovial Germinal Centers in Patients with Rheumatoid and Reactive Arthritis. J Immunol, 162, 3053-3062 (1999) (Pubitemid 29309336)
122. Edwards, J. C. W. & G. Cambridge: Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes. Rheumatology, 40, 205-211 (2001)
123. Edwards, J. C. W., L. Szczepanski, J. Szechinski, A. Filipowicz- Sosnowska, P. Emery, D. R. Close, R. M. Stevens & T. Shaw: Efficacy of B-Cell-Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis. N Engl J Med, 350, 2572-2581 (2004) (Pubitemid 38758544)
124. van Vollenhoven, R. F., J. Schechtman, L. J. Szczepanski, R. M. Fleischmann, B. L. Hazleman, P. T. Nash, N. F. Li, K. L. Sewell, K. A. Rowe & T. H.: Safety and Tolerability of Rituximab in Patients with Moderate to Severe Rheumatoid Arthritis: Results from the Dose-Ranging Assessment International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) study. Arthritis Rheum, 52, (2005)
125. M. F. R., K. Pavelka, A. R. Baldassare, E. Martin-Mola, P. C. Chatpar, P. T. Nash, P. Emery, E. W. Hessey, P. B. Lehane, N. Li, F. & K. L. Sewell: Preliminary Efficacy Results of Rituximab Retreatment in Patients with Active Rheumatoid Arthritis. Arthritis Rheum, 52, S131 (2005)
126. Cohen, S. B., M. Greenwald, M. R. Dougados, P. Emery, R. Furie, T. M. Shaw & M. C. Totoritis: Efficacy and Safety of Rituximab in Active R A Patients who Experienced an Inadequate Response to one or More Anti-T N F α Therapies (R E F L E X Study). Arthritis Rheum 52, S677 (2005)
127. Keystone, E. C., G. R. Burmester, R. Furie, J. E. Loveless, P. Emery, M. W. Cravets & F. Magrini: Improved Quality of Life with Rituximab Plus Methotrexate in Patients with Active Rheumatoid Arthritis who Experienced Inadequate Response to one or More Anti-T N F-α Therapies. Arthritis Rheum, 52, S141 (2005)
128. Fleischmann, R. M., A. J. Racewicz, J. Schechtman, M. M. Khraishi, G. F. Ferraccioli, E. Hessey, T. M. Shaw, N. F. Li & S. Agarwal: Rituximab Efficacy in Rheumatoid Arthritis is Independent of Coadministration of Glucocorticoids: Results from the Dose-Ranging Assessment International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Study. Arthritis Rheum 52, (2005)
129. Albert, D., S. Khan, J. Stansberry, S. Kolasinski, D. Tsai, M. Kamoun & R. Eisenberg: A phase I trial of rituximab (anti-CD20) for treatment of systemic lupus erythematosus. Arthritis Rheum, 50, S446 (2004)
130. Leandro, M. J., G. Cambridge, J. C. Edwards, M. R. Ehrenstein & D. A. Isenberg: B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients. Rheumatology, 44, 1542-1545 (2005) (Pubitemid 41742472)
131. Anolik, J. H., J. Barnard, A. Cappione, A. E. Pugh-Bernard, R. E. Felgar, R. J. Looney & I. Sanz: Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. Arthritis Rheum, 50, 3580-90. (2004) (Pubitemid 39488683)
132. Anolik, J. H., D. Campbell, R. E. Felgar, F. Young, I. Sanz, J. Rosenblatt & R. J. Looney: The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus. Arthritis Rheum, 48, 455-459. (2003) (Pubitemid 36278014)
133. Dall'Ozzo, S., S. Tartas, G. Paintaud, G. Cartron, P. Colombat, P. Bardos, H. Watier & G. Thibault: Rituximab-Dependent Cytotoxicity by Natural Killer Cells: Influence of FCGR3A Polymorphism on the Concentration-Effect Relationship. Cancer Res, 64, 4664-4669 (2004) (Pubitemid 38856941)
134. Weng, W.-K., D. Czerwinski, J. Timmerman, F. J. Hsu & R. Levy: Clinical Outcome of Lymphoma Patients After Idiotype Vaccination Is Correlated With Humoral Immune Response and Immunoglobulin G Fc Receptor Genotype. J Clin Oncol, 22, 4717-4724 (2004)
135. Hamaguchi, Y., Y. Xiu, K. Komura, F. Nimmerjahn & T. F. Tedder: Antibody isotype-specific engagement of Fc{gamma} receptors regulates B lymphocyte depletion during CD20 immunotherapy. J. Exp. Med.jem. 2005 2283 (2006)
136. van Vollenhoven, R. F., I. Gunnarsson, E. Welin-Henriksson, T. Jonsdottir, B. Sundelin, S. Jacobsson & L. Klareskog: Rituximab Plus Cyclophosphamide in Severe SLE: Results in 15 Patients Who Failed Conventional Immunosuppressive Therapy. Arthritis Rheum, 52, (2005)
137. Sfikakis, P. P., J. N. Boletis, S. Lionaki, V. Vigklis, K. G. Fragiadaki, A. Iniotaki & H. M. Moutsopoulos: Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial. Arthritis Rheum, 52, 501-13 (2005) (Pubitemid 40216314)
138. Neuwelt, C. M. Y., R. A. McGhee & J. Freeman: Role of Rituximab in the treatment of severe central nervous system neuropsychiatric lupus erythematous as monotherapy or in combination therapy. Eular Abstracts Online (2005)
139. Tokunaga, M., K. Fujii, K. Saito, S. Nakayamada, S. Tsujimura, M. Nawata
140. Hoffman, G. S, Kerr, G. S, Leavitt, R. Y, Hallahan, C. W, Lebovics, R. S, Travis, W. D, Rottem, M, Fauci, A. S: Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med, 116, 488-98. (1992)
141. Jayne, D., N. Rasmussen, K. Andrassy, P. Bacon, J. W. C. Tervaert, J. Dadoniene, A. Ekstrand, G. Gaskin, G. Gregorini, K. de Groot, W. Gross, E. C. Hagen, E. Mirapeix, E. Pettersson, C. Siegert, A. Sinico, V. Tesar, K. Westman, C. Pusey & G. the European Vasculitis Study: A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies. N Engl J Med, 349, 36-44 (2003) (Pubitemid 36765101)
142. Keogh, K. A., M. E. Wylam, J. H. Stone & U. Specks: Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum, 52, 262-8 (2005) (Pubitemid 40129256)
143. Eriksson, P.: Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab. J. Inter. Med., 257, 540-548 (2005) (Pubitemid 40776514)
144. Panayi, G. S., J. D. Hainsworth, R. J. Looney & E. C. Keystone: Panel discussion on B cells and rituximab: mechanistic aspects, efficacy and safety in rheumatoid arthritis and non-Hodgkin's lymphoma. Rheumatology, 44, ii18-20 (2005)
145. Gong, Q., Q. Ou, S. Ye, W. P. Lee, J. Cornelius, L. Diehl, W. Y. Lin, Z. Hu, Y. Lu, Y. Chen, Y. Wu, Y. G. Meng, P. Gribling, Z. Lin, K. Nguyen, T. Tran, Y. Zhang, H. Rosen, F. Martin & A. C. Chan: Importance of Cellular Microenvironment and Circulatory Dynamics in B Cell Immunotherapy. J Immunol, 174, 817-826 (2005) (Pubitemid 40094277)
146. Hamaguchi, Y., J. Uchida, D. W. Cain, G. M. Venturi, J. C. Poe, K. M. Haas & T. F. Tedder: The Peritoneal Cavity Provides a Protective Niche for B1 and Conventional B Lymphocytes during Anti-CD20 Immunotherapy in Mice. J Immunol, 174, 4389-4399 (2005) (Pubitemid 40396022)
147. Eisenberg, R.: SLE - Rituximab in lupus. Arthritis Res Ther, 5, 157-159 (2003)
148. Cambridge, Stohl, W, Leandro, M. J, Migone, T.-S., Hilbert, M. D, Edwards, J. C. W.: Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: Relationships with B cell depletion, circulating antibodies, and clinical relapse. Arthritis Rheum, 54, 723-732 (2006)
149. Leandro, M. J, Cambridge, G, Ehrenstein, M. R, Edwards, J. C. W.: Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis. Arthritis Rheum, 54, 613-620 (2006) (Pubitemid 43228639)
150. Anolik, J. H., J. Barnard, T. Owen, E. Cushing, D. Campbell, R. J. Looney & I. Sanz: B cell reconstitution after rituximab in SLE is characterized by increased transitional B cells and delayed memory B cell recovery. Submitted (2005)
151. Binstadt, B. A., A. M. C. Caldas, S. E. Turvey, H. J. Weinstein, J. Jackson, R. C. Fuhlbrigge & R. P. Sundel: Rituximab therapy for multisystem autoimmune diseases in pediatric patients. J. Pediatr. 143, 598-604 (2003) (Pubitemid 37452785)
152. Quartier, P., B. Brethon, P. Philippet, J. Landman-Parker, F. Le Deist & A. Fischer: Treatment of childhood autoimmune haemolytic anaemia with rituximab. The Lancet, 358, 1511-1513 (2001) (Pubitemid 33055705)
153. Gonzalez-Stawinski, G. V., P. B. Yu, S. D. Love, W. Parker & J. R. D. Davis: Hapten-Induced Primary and Memory Humoral Responses Are Inhibited by the Infusion of Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab). Clin. Immunol, 98, 175-179 (2001)
154. Bearden, C. M., A. Agarwal, B. K. Book, C. A. Vieira, R. A. Sidner, H. D. Ochs, M. Young & M. D. Pescovitz: Rituximab Inhibits the In Vivo Primary and Secondary Antibody Response to a Neoantigen, Bacteriophage phiX174. American Journal of Transplantation, 5, 50-57 (2005) (Pubitemid 40095127)
155. Slifka, M. K., R. Antia, J. K. Whitmire & R. Ahmed: Humoral immunity due to long-lived plasma cells. Immunity, 8, 363-72 (1998) (Pubitemid 28188896)
156. Manz, R. A., A. Thiel & A. Radbruch: Lifetime of plasma cells in the bone marrow. Nature, 388, 133-4. (1997) (Pubitemid 27297440)
157. Ho, F., J. E. Lortan, I. C. MacLennan & M. Khan: Distinct short-lived and long-lived antibody-producing cell populations. Eur J Immunol, 16, 1297-301. (1986) (Pubitemid 17171537)
158. Jacob, J. & G. Kelsoe: In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl) acetyl. II. A common clonal origin for periarteriolar lymphoid sheathassociated foci and germinal centers. J. Exp. Med, 176, 679-87 (1992)
159. Garcia de Vinuesa, C., P. O'Leary, D. M. Sze, K. M. Toellner & I. C. MacLennan: T-independent type 2 antigens induce B cell proliferation in multiple splenic sites, but exponential growth is confined to extrafollicular foci. Eur. J. Immunol, 29, 1314-23 (1999) (Pubitemid 29164178)
160. Sze, D. M., K. M. Toellner, C. G. de Vinuesa, D. R. Taylor & I. C. MacLennan: Intrinsic Constraint on Plasmablast Growth and Extrinsic Limits of Plasma Cell Survival. J Exp Med, 192, 813-822 (2000)
161. Hoyer, B. F., K. Moser, A. E. Hauser, A. Peddinghaus, C. Voigt, D. Eilat, A. Radbruch, F. Hiepe & R. A. Manz: Short-lived Plasmablasts and Long-lived Plasma Cells Contribute to Chronic Humoral Autoimmunity in NZB/W Mice. J. Exp. Med.jem. 2004 0168 (2004)
162. William, J., C. Euler, S. Christensen & M. J. Shlomchik: Evolution of Autoantibody Responses via Somatic Hypermutation Outside of Germinal Centers. Science, 297, 2066-2070 (2002)
163. Bernasconi, N. L., E. Traggiai & A. Lanzavecchia: Maintenance of serological memory by polyclonal activation of human memory B cells. Science, 298, 2199-202. (2002) (Pubitemid 35471246)
164. Stott, D. I., F. Hiepe, M. Hummel, G. Steinhauser & C. Berek: Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjogren's syndrome. J Clin Invest, 102, 938-946 (1998) (Pubitemid 28419239)
165. Cassese, G., S. Lindenau, B. de Boer, S. Arce, A. Hauser, G. Riemekasten, C. Berek, F. Hiepe, V. Krenn, A. Radbruch & R. A. Manz: Inflamed kidneys of NZB/W mice are a major site for the homeostasis of plasma cells. Eur. J. Immunol, 31, 2726-32 (2001) (Pubitemid 32898740)
166. Wiestner, A., H. J. Cho, A. S. Asch, M. A. Michelis, J. A. Zeller, E. I. B. Peerschke, B. B. Weksler & G. P. Schechter: Rituximab in the treatment of acquired factor VIII inhibitors. Blood, 100, 3426-3428 (2002) (Pubitemid 35217098)
167. Sanz, I. & J. Anolik: Reconstitution of the adult B cell repertoire after treatment with rituximab. Arthritis Res Ther, 7, 175-6 (2005) (Pubitemid 41335148)
168. Anolik, J., J. Barnard, T. Owen, E. Cushing, D. J. Campbell, R. J. Looney, J. Friedberg, R. Fisher & I. Sanz: B cell reconstitution after rituximab is characterized by a preponderance of transitional B cells. Blood, Submitted., (2005)
169. Rouziere, A.-S., C. Kneitz, A. Palanichamy, T. Dorner & H.-P. Tony: Regeneration of the immunoglobulin heavychain repertoire after transient B-cell depletion with an anti-CD20 antibody. Arthritis Research & Therapy, 7, R714 - R724 (2005)
170. Anolik, J., J. Barnard, R. J. Looney & I. Sanz: Long-Term Effects of Rituximab in the Treatment of Systemic Lupus Erythematosus. Arthritis Rheum 52, S190 (2005)
171. Cuss, A. K., D. T. Avery, J. L. Cannons, L. J. Yu, K. E. Nichols, P. J. Shaw & S. G. Tangye: Expansion of Functionally Immature Transitional B Cells Is Associated with Human-Immunodeficient States Characterized by Impaired Humoral Immunity. J Immunol, 176, 1506-1516 (2006) (Pubitemid 43134294)
172. Pugh-Bernard, A. E., G. J. Silverman, A. J. Cappione, M. E. Villano, D. H. Ryan, R. A. Insel & I. Sanz: Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J Clin Invest, 108, 1061-1070. (2001) (Pubitemid 32946080)
173. Cappione, A., III, J. H. Anolik, A. Pugh-Bernard, J. Barnard, P. Dutcher, G. Silverman & I. Sanz: Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J. Clin. Invest., 115, 3205-3216 (2005) (Pubitemid 41567585)
174. Eisenberg, R. A., S. Y. Craven, R. W. Warren & P. L. Cohen: Stochastic control of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice. J. Clin. Invest, 80, 691-7 (1987) (Pubitemid 18003939)
175. Chung, J. B., A. D. Wells, S. Adler, A. Jacob, L. A. Turka & J. G. Monroe: Incomplete Activation of CD4 T Cells by Antigen-Presenting Transitional Immature B Cells: Implications for Peripheral B and T Cell Responsiveness. J Immunol, 171, 1758-1767 (2003) (Pubitemid 36966458)
176. Eynon, E. & D. Parker: Small B cells as antigenpresenting cells in the induction of tolerance to soluble protein antigens. J. Exp. Med., 175, 131-138 (1992)
177. Ho, W. Y., M. P. Cooke, C. C. Goodnow & M. M. Davis: Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells. J. Exp. Med, 179, 1539-49 (1994) (Pubitemid 24129571)
178. Wallerskog, T., I. Gunnarsson, R. F. van Vollenhoven, V. Malmstrom & C. Trollmo: Immunological Characterization Can Predict The Outcome Of Rituximab Treatment In Patients With SLE. Arthritis Rheum (2004)
179. Sfikakis, P. P., J. N. Boletis, S. Lionaki, V. Vigklis, V. Fragiadaki, A. Iniotaki & H. M. Moutsopoulos: Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: An open-label trial. Arthritis Rheum 52, 501-513 (2005) (Pubitemid 40216314)
180. Ronald van Vollenhoven, I. G.: In lupus nephritis, the benefit of rituximab monotherapy, as opposed to rituximab plus cyclophosphamide combination therapy, remains uncertain: Comment on the article by Sfikakis et al. Arthritis Rheum, 52, 4050-4051 (2005)
181. Akahoshi, M., H. Nakashima, Y. Tanaka, T. Kohsaka, S. Nagano, E. Ohgami, Y. Arinobu, K. Yamaoka, H. Niiro, M. Shinozaki, H. Hirakata, T. Horiuchi, T. Otsuka & Y. Niho: Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum, 42, 1644-8 (1999) (Pubitemid 30263632)
182. Tanaka, Y. & M. Tokunaga: Rituximab reduces both quantity and quality of B cells in SLE: reply. Rheumatologykei 189 (2005)
183. Peng, S. L., J. Moslehi & J. Craft: Roles of interferongamma and interleukin-4 in murine lupus. J. Clin. Invest. 99, 1936-46 (1997) (Pubitemid 27175941)
184. Lovgren, T., M. Eloranta, U. Bave, G. Alm & L. Ronnblom: Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum, 50, 1861-72 (2004) (Pubitemid 38725099)
185. Storek, J., S. Ferrara, N. Ku, J. V. Giorgi, R. E. Champlin & A. Saxon: B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny? Bone Marrow Transplant, 12, 387-98. (1993) (Pubitemid 23295523)
186. Seo, S. J., M. L. Fields, J. L. Buckler, A. J. Reed, L. Mandik-Nayak, S. A. Nish, R. J. Noelle, L. A. Turka, F. D. Finkelman, A. J. Caton & J. Erikson: The impact of T helper and T regulatory cells on the regulation of antidouble-stranded DNA B cells. Immunity., 16, 535-46 (2002) (Pubitemid 34442578)
187. Sekiguchi, D. R., S. M. Jainandunsing, M. L. Fields, M. A. Maldonado, M. P. Madaio, J. Erikson, M. Weigert & R. A. Eisenberg: Chronic Graft-Versus-Host in Ig Knockin Transgenic Mice Abrogates B Cell Tolerance in Anti-Double-Stranded DNA B Cells. J Immunol, 168, 4142-4153 (2002) (Pubitemid 34298423)
188. Lim, H. W., P. Hillsamer, A. H. Banham & C. H. Kim: Cutting Edge: Direct Suppression of B Cells by CD4+CD25+ Regulatory T Cells. J Immunol, 175, 4180-4183 (2005) (Pubitemid 41361949)
189. Zhao, D.-M., A. M. Thornton, R. J. DiPaolo & E. M. Shevach: Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood 2005-11-4502 (2006)
190. Ramanujam, M., X. Wang, W. Huang, Z. Liu, L. Schiffer, H. Tao, D. Frank, J. Rice, B. Diamond, K. O. A. Yu, S. Porcelli & A. Davidson: Similarities and differences between selective and nonselective BAFF blockade in murine SLE. J. Clin. Invest., 116, 724-734 (2006) (Pubitemid 43326881)
191. Zand, M. S., T. Vo, T. Pellegrin, R. Felgar, J. L. Liesveld, J. J. Ifthikharuddin, C. N. Abboud, I. Sanz & J. Huggins: Apoptosis and complement mediated lysis of myeloma cells by polyclonal rabbit anti-thymocyte globulin. Blood 2005-06-2269 (2005)
192. Zand, M. S., T. Vo, J. Huggins, R. Felgar, J. Liesveld, T. Pellegrin, A. Bozorgzadeh, I. Sanz & B. J. Briggs: Polyclonal Rabbit Antithymocyte Globulin Triggers B-Cell and Plasma Cell Apoptosis by Multiple Pathways. Transplantation, 79, 1507-1515 (2005) (Pubitemid 40847581)
193. Minamimura, K., W. Gao & T. Maki: CD4+ Regulatory T Cells Are Spared from Deletion by Antilymphocyte Serum, a Polyclonal Anti-T Cell Antibody. J Immunol, 176, 4125-4132 (2006) (Pubitemid 44264391)
194. Tedder, T. F., J. C. Poe & K. M. Haas: CD22: A Multifunctional Receptor That Regulates B Lymphocyte Survival and Signal Transduction. In: Advances in Immunology. Academic Press, (2005)
195. Fukuyama, H., F. Nimmerjahn & J. V. Ravetch: The inhibitory Fcgamma receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells. Nat Immunol, 6, 99-106. Epub 2004 Dec. 12. (2005) (Pubitemid 40136701)
196. Lenert, P.: Inhibitory oligodeoxynucleotides: therapeutic promise for systemic autoimmune diseases? Clin. Exp. Immunol. 140, 1-10 (2005) (Pubitemid 40461067)
197. Rifkin, I. R., E. A. Leadbetter, L. Busconi, G. Viglianti & A. Marshak-Rothstein: Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol Rev, 204, 27-42. (2005) (Pubitemid 40460491)
198. Tahir, H., J. Rohrer, A. Bhatia, W. A. Wegener & D. A. Isenberg: Humanized anti-CD20 monoclonal antibody in the treatment of severe resistant systemic lupus erythematosus in a patient with antibodies against rituximab. Rheumatologykeh 533 (2005)
199. Ng, K. P., M. J. Leandro, J. C. W. Edwards, M. Ehrenstein, G. Cambridge & D. A. Isenberg: Repeated B cell depletion in treatment of refractory systemic lupus erythematosus. Ann Rheum Disard. 2005. 044487 (2005)
200. Tsutsumi, Y., H. Kanamori, A. Mori, J. Tanaka, M. Asaka, M. Imamura & N. Masauzi: Reactivation of hepatitis B virus with rituximab. Expert Opinion on Drug Safety, 4, 599-608 (2005) (Pubitemid 40723731)
201. Dervite, I., D. Hober & P. Morel: Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab. N Engl J Med, 344, 68-9. (2001) (Pubitemid 32064857)
202. Niscola, P., M. I. Del Principe, L. Maurillo, A. Venditti, F. Buccisano, D. Piccioni, S. Amadori & G. Del Poeta: Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy. Leukemia, 19, 1840-1841 (2005) (Pubitemid 41486166)
203. Sato, S., M. Fujimoto, M. Hasegawa, K. Takehara & T. F. Tedder: Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis. Mol. Immunol. 41, 1123-1133 (2004) (Pubitemid 39346261)
204. Michaels, P. J., M. C. Fishbein & R. B. Colvin: Humoral rejection of human organ transplants. Springer Semin Immunopathol, 25, 119-40. (2003)
205. Sidner, R. A., B. K. Book, A. Agarwal, C. M. Bearden, C. A. Vieira & M. D. Pescovitz: In vivo human B-cell subset recovery after in vivo depletion with rituximab, anti-human CD20 monoclonal antibody. Hum Antibodies, 13, 55-62. (2004) (Pubitemid 40164116)
206. Hogg, J. C., F. Chu, S. Utokaparch, R. Woods, W. M. Elliott, L. Buzatu, R. M. Cherniack, R. M. Rogers, F. C. Sciurba, H. O. Coxson & P. D. Pare: The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease. N Engl J Med, 350, 2645-2653 (2004) (Pubitemid 38787999)
207. Beier, K. C., A. Hutloff, M. Lohning, T. Kallinich, R. A. Kroczek & E. Hamelmann: Inducible costimulatorpositive T cells are required for allergen-induced local B-cell infiltration and antigen-specific IgE production in lung tissue. J. Allergy. Clin. Immunol. 114, 775-782 (2004) (Pubitemid 39330246)
208. Qin, Z., G. Richter, T. Schuler, S. Ibe, X. Cao & T. Blankenstein: B cells inhibit induction of T cell-dependent tumor immunity. Nat Med, 4, 627-30 (1998) (Pubitemid 28237366)
209. Perricone, M. A., K. A. Smith, K. A. Claussen, M. S. Plog, D. M. Hempel, B. L. Roberts, J. A. St George & J. M. Kaplan: Enhanced efficacy of melanoma vaccines in the absence of B lymphocytes. J Immunother, 27, 273-81 (2004) (Pubitemid 38833323)
210. Ochsenbein, A. F. & R. Zinkernagel: Natural antibodies and complement link innate and acquired immunity. Immunol. Today, 21, 624-630 (2000) (Pubitemid 32044019)
211. Carsetti, R., M. M. Rosado, S. Donnanno, V. Guazzi, A. Soresina, A. Meini, A. Plebani, F. Aiuti & I. Quinti: The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J. Allergy. Clin. Immunol, 115, 412-417 (2005) (Pubitemid 40215112)
212. Baker, N. & M. R. Ehrenstein: Cutting Edge: Selection of B Lymphocyte Subsets Is Regulated by Natural IgM. J Immunol, 169, 6686-90. (2002) (Pubitemid 36899252)
213. Boes, M., A. P. Prodeus, T. Schmidt, M. C. Carroll & J. Chen: A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J. Exp. Med, 188, 2381-6 (1998) (Pubitemid 29028511)
214. Boes, M., T. Schmidt, K. Linkemann, B. C. Beaudette, A. Marshak-Rothstein & J. Chen: Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc. Natl. Acad. Sci. USA, 97, 1184-9 (2000) (Pubitemid 30080833)
215. Ehrenstein, M. R., H. T. Cook & M. S. Neuberger: Deficiency in serum immunoglobulin (Ig) M predisposes to development of IgG autoantibodies. J. Exp. Med, 191, 1253-8 (2000)
216. Binder, C. J. & G. J. Silverman: Natural antibodies and the autoimmunity of atherosclerosis. Springer Seminars in Immunopathology, 26, 385-404 (2005) (Pubitemid 40468892)
217. Bili, A., A. J. Moss, C. W. Francis, W. Zareba, L. F. M. Watelet & I. Sanz: Anticardiolipin antibodies and recurrent coronary events - A prospective study of 1150p atients. Circulation, 102, 1258-1263 (2000)
218. Laura Broglio, G. L.: Worsening after rituximab treatment in anti-mag neuropathy. Muscle & Nerve, 32, 378-379 (2005)
219. Noronha, V., T. M. Fynan & T. Duffy: Flare in Neuropathy Following Rituximab Therapy for Waldenstrom's Macroglobulinemia. J Clin Oncol, 24, 3e (2006)